These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8460321)

  • 1. [The risks of viral transmission by bone allografts].
    Rev Infirm; 1993 Jan; 43(2):37. PubMed ID: 8460321
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmission of disease through transplantation of musculoskeletal allografts.
    Tomford WW
    J Bone Joint Surg Am; 1995 Nov; 77(11):1742-54. PubMed ID: 7593087
    [No Abstract]   [Full Text] [Related]  

  • 3. Infection in Bone Allograft Transplants.
    Zamborsky R; Svec A; Bohac M; Kilian M; Kokavec M
    Exp Clin Transplant; 2016 Oct; 14(5):484-490. PubMed ID: 27733106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in prevalence of viral infections in Australian musculoskeletal tissue donors and projections of incidence and residual risk, 1993-2004.
    Yao F; Seed C; Kiely P; Parker S; Qian Y; Farrugia A; Morgan D; Wood D; Zheng MH
    Transplantation; 2008 Sep; 86(5):746-8. PubMed ID: 18791459
    [No Abstract]   [Full Text] [Related]  

  • 5. p24 antigen screening to reduce the risk of HIV transmission by seronegative bone allograft donors.
    Malhotra R; Morgan DA
    Natl Med J India; 2000; 13(4):190-2. PubMed ID: 11002686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections transmitted through musculoskeletal-tissue allografts.
    Patel R; Trampuz A
    N Engl J Med; 2004 Jun; 350(25):2544-6. PubMed ID: 15201409
    [No Abstract]   [Full Text] [Related]  

  • 7. Complications of allografts in arthroplasty.
    Habermann ET; Bosco JA
    Semin Arthroplasty; 1993 Apr; 4(2):64-7. PubMed ID: 10148545
    [No Abstract]   [Full Text] [Related]  

  • 8. Transmission of viruses with human allografts.
    Griffiths P
    Rev Med Virol; 2007; 17(3):147-9. PubMed ID: 17471600
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of allograft bone in spine surgery: is it safe?
    Mroz TE; Joyce MJ; Lieberman IH; Steinmetz MP; Benzel EC; Wang JC
    Spine J; 2009 Apr; 9(4):303-8. PubMed ID: 18805063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allograft safety: viral inactivation with bone demineralization.
    Scarborough NL; White EM; Hughes JV; Manrique AJ; Poser JW
    Contemp Orthop; 1995 Oct; 31(4):257-61. PubMed ID: 10163469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of disease transmission with bone allograft.
    Ng VY
    Orthopedics; 2012 Aug; 35(8):679-81. PubMed ID: 22868589
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of virus transmission by tissue, blood, and plasma products.
    Lelie PN; Zaaijer HL; Cuypers HT
    Transplant Proc; 1996 Oct; 28(5):2939. PubMed ID: 8908132
    [No Abstract]   [Full Text] [Related]  

  • 13. Infections associated with musculoskeletal-tissue allografts.
    Pruss A; Göbel UB; Pauli G
    N Engl J Med; 2004 Sep; 351(13):1358-60; author reply 1358-60. PubMed ID: 15390366
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a bacteriophage model system to investigate virus inactivation methods used in the treatment of bone allografts.
    Bienek C; MacKay L; Scott G; Jones A; Lomas R; Kearney JN; Galea G
    Cell Tissue Bank; 2007; 8(2):115-24. PubMed ID: 17061148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.
    Ninin E; Milpied N; Moreau P; André-Richet B; Morineau N; Mahé B; Vigier M; Imbert BM; Morin O; Harousseau JL; Richet H
    Clin Infect Dis; 2001 Jul; 33(1):41-7. PubMed ID: 11389493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients' pool.
    Donoso Mantke O; Meyer R; Prösch S; Nitsche A; Leitmeyer K; Kallies R; Niedrig M
    J Heart Lung Transplant; 2005 Oct; 24(10):1632-8. PubMed ID: 16210141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate screening for prevention of infection transmission by musculoskeletal allografts.
    Friedlaender GE
    Instr Course Lect; 2000; 49():615-9. PubMed ID: 10829217
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of viral transmission via bone marrow progenitor cells versus umbilical cord blood hematopoietic stem cells in bone marrow transplantation.
    Behzad-Behbahani A; Pouransari R; Tabei SZ; Rahiminejad MS; Robati M; Yaghobi R; Nourani H; Ramzi MM; Farhadi-Andarabi A; Mojiri A; Rahsaz M; Banihashemi M; Zare N
    Transplant Proc; 2005 Sep; 37(7):3211-2. PubMed ID: 16213350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the risk of viral infection between the living and nonliving musculoskeletal tissue donors in Australia.
    Yao F; Seed C; Farrugia A; Morgan D; Wood D; Zheng MH
    Transpl Int; 2008 Oct; 21(10):936-41. PubMed ID: 18537922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential for HIV transmission through allogeneic bone. A review of risks and safety.
    Carlson ER; Marx RE; Buck BE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jul; 80(1):17-23. PubMed ID: 7552853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.